LEONI, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 779
NA - Nord America 774
EU - Europa 648
SA - Sud America 162
AF - Africa 27
OC - Oceania 1
Totale 2.391
Nazione #
US - Stati Uniti d'America 737
SG - Singapore 330
IT - Italia 258
CN - Cina 168
BR - Brasile 134
DE - Germania 106
HK - Hong Kong 104
FI - Finlandia 52
GB - Regno Unito 45
VN - Vietnam 42
FR - Francia 36
RU - Federazione Russa 35
TR - Turchia 25
IN - India 24
PL - Polonia 23
CZ - Repubblica Ceca 21
BD - Bangladesh 17
CA - Canada 17
MX - Messico 16
ZA - Sudafrica 16
NL - Olanda 14
JP - Giappone 13
SE - Svezia 11
AR - Argentina 9
IE - Irlanda 9
AT - Austria 8
ES - Italia 8
TH - Thailandia 8
CO - Colombia 7
ID - Indonesia 7
IQ - Iraq 7
UA - Ucraina 6
BE - Belgio 5
IR - Iran 5
AE - Emirati Arabi Uniti 4
LK - Sri Lanka 4
MA - Marocco 4
OM - Oman 4
TW - Taiwan 4
EG - Egitto 3
PS - Palestinian Territory 3
PT - Portogallo 3
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
EC - Ecuador 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
LT - Lituania 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
JM - Giamaica 1
KE - Kenya 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.391
Città #
Singapore 137
Ashburn 108
Hong Kong 103
New York 70
Munich 63
Brescia 61
Beijing 46
Los Angeles 46
Dallas 40
Milan 34
Des Moines 31
Helsinki 29
Chandler 27
Boardman 25
Istanbul 18
Shanghai 17
Turku 17
San Francisco 16
São Paulo 16
Brno 15
Ho Chi Minh City 15
Redondo Beach 15
Tokyo 13
Warsaw 13
Barlassina 12
Seattle 12
Chicago 11
Santa Clara 11
The Dalles 11
Frankfurt am Main 10
Hanoi 10
Johannesburg 10
London 10
Nuremberg 10
Poplar 10
Rome 10
Wroclaw 10
Buffalo 9
Dublin 9
Romola 9
Stockholm 9
Mexico City 8
Moscow 8
Brooklyn 7
Orem 7
Toronto 7
Boston 6
Fairfield 6
Manchester 6
Princeton 6
Atlanta 5
Bangkok 5
Chennai 5
Denver 5
Düsseldorf 5
Lappeenranta 5
Olomouc 5
Verona 5
Brussels 4
Charlotte 4
Colombo 4
Houston 4
Jakarta 4
Maple Grove 4
Poncarale 4
Pune 4
Sommacampagna 4
Sulaymaniyah 4
Turin 4
Ancona 3
Belo Horizonte 3
Bologna 3
Brasília 3
Cremona 3
Curitiba 3
Da Nang 3
Florence 3
Kolkata 3
Lisbon 3
Montreal 3
Nakhon Ratchasima 3
Palermo 3
Phoenix 3
Pisogne 3
Portsmouth 3
Salvador 3
Shijiazhuang 3
Telgate 3
Thái Bình 3
Tianjin 3
Woodbridge 3
Addis Ababa 2
Alvorada 2
Amsterdam 2
Ankara 2
Ann Arbor 2
Araraquara 2
Arcoverde 2
Athens 2
Babol 2
Totale 1.377
Nome #
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 135
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 121
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) 105
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 104
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 93
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 92
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 91
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 87
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 86
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 85
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 83
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 81
How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation 78
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 77
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 76
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 75
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 74
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 73
Feasibility Study on detection and monitoring of gene-mutations by digital (dPCR) NGS driven in patients with Acute Myeloid Leukemias (AMLs) and High-Risk Myelodysplastic Syndromes (HR-MDSs)- “dPCR-NGS Driven Study” 71
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 71
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial 69
Secondary Myeloid Neoplasms after CD19 CAR-T Cell Therapy: Real-Life Multicenter Data from the Clonhema Study 66
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 66
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 65
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 63
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients 61
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 57
The Applications of Machine Learning in the Management of Patients Undergoing Stem Cell Transplantation: Are We Ready? 56
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 49
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study 47
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 45
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles 19
Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML) 6
Totale 2.427
Categoria #
all - tutte 13.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 3 0 4
2021/202241 0 0 2 0 0 0 5 10 3 9 3 9
2022/2023132 4 1 8 23 8 26 0 12 14 4 16 16
2023/2024284 5 7 16 16 28 49 17 17 39 10 8 72
2024/2025932 8 28 25 72 57 61 72 44 164 105 166 130
2025/20261.031 138 176 150 281 251 35 0 0 0 0 0 0
Totale 2.427